|
|
Blood, 1 August 2007, Vol. 110, No. 3, pp. 847-850.
Prepublished online as a Blood First Edition Paper on April 5, 2007; DOI 10.1182/blood-2007-01-067546.
Previous Article | Next Article 
Submitted January 10, 2007
Accepted April 2, 2007
CD4+CD25high Foxp3+ regulatory T-cells in Myelodysplastic Syndrome (MDS)
Shahram Y Kordasti, Wendy Ingram, Janet Hayden, David Darling, Linda Barber, Behdad Afzali, Giovanna Lombardi, Marcin W Wlodarski, Jaroslaw P Maciejewski, Farzin Farzaneh, and Ghulam J Mufti*
Dept of Haematological Medicine, King's College London, London, United Kingdom
Immunoregulation Laboratory, Dept of Nephrology and Transplantation, King's College London, London, United Kingdom
Experimental Hematology & Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, United States
* Corresponding author; email: ghulam.mufti{at}kcl.ac.uk.
Foxp3+ regulatory T-cells (Treg) play a central role in maintaining immune tolerance. A reduction in the function of Tregs is a key feature of autoimmune diseases, whereas their expansion in malignant diseases leads to the suppression of host anti-tumor responses. We analyzed the absolute number of CD4+ and CD8+Tregs in the peripheral blood of 52 MDS patients and show a significant correlation between increased number of CD4+Tregs and MDS subgroups with 5% bone marrow blasts (p<0.001), high IPSS (p<0.001), and disease progression (p<0.001) whereas no correlation between CD8+Tregs and prognostic variables was observed. The CD4+Tregs showed a polyclonal spectratype and the percentage of the naive subset was significantly higher in the high risk patients compared to low risk or normal age matched donors (p=0.032). Our data suggests that CD4+Tregs expansion is a feature of high risk MDS and progression to aggressive subtypes of the disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Tefferi and J. W. Vardiman
Myelodysplastic Syndromes
N. Engl. J. Med.,
November 5, 2009;
361(19):
1872 - 1885.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, R. Lau, D. Yu, W. Zhu, A. Korman, and J. Weber
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
Int. Immunol.,
September 1, 2009;
21(9):
1065 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kotsianidis, E. Nakou, I. Bouchliou, A. Tzouvelekis, E. Spanoudakis, P. Steiropoulos, I. Sotiriou, V. Aidinis, D. Margaritis, C. Tsatalas, et al.
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
June 15, 2009;
179(12):
1121 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mougiakakos, C. C. Johansson, and R. Kiessling
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
Blood,
April 9, 2009;
113(15):
3542 - 3545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Barrett and E. Sloand
Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance
Haematologica,
April 1, 2009;
94(4):
449 - 451.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E.D. Chamuleau, T. M. Westers, L. van Dreunen, J. Groenland, A. Zevenbergen, C. M. Eeltink, G. J. Ossenkoppele, and A. A. van de Loosdrecht
Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome
Haematologica,
April 1, 2009;
94(4):
496 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Curti, S. Trabanelli, V. Salvestrini, M. Baccarani, and R. M. Lemoli
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
Blood,
March 12, 2009;
113(11):
2394 - 2401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mittal, N. A. Marshall, L. Duncan, D. J. Culligan, R. N. Barker, and M. A. Vickers
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
Blood,
June 1, 2008;
111(11):
5359 - 5370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Feng, S. Kajigaya, E. E. Solomou, K. Keyvanfar, X. Xu, N. Raghavachari, P. J. Munson, T. M. Herndon, J. Chen, and N. S. Young
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Blood,
April 1, 2008;
111(7):
3675 - 3683.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|